GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Cyclically Adjusted PS Ratio

SANUWAVE Health (SANUWAVE Health) Cyclically Adjusted PS Ratio : 0.90 (As of May. 01, 2024)


View and export this data going back to 2008. Start your Free Trial

What is SANUWAVE Health Cyclically Adjusted PS Ratio?

As of today (2024-05-01), SANUWAVE Health's current share price is $0.018. SANUWAVE Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.02. SANUWAVE Health's Cyclically Adjusted PS Ratio for today is 0.90.

The historical rank and industry rank for SANUWAVE Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

SNWV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.07   Med: 5.33   Max: 19.67
Current: 1.06

During the past years, SANUWAVE Health's highest Cyclically Adjusted PS Ratio was 19.67. The lowest was 0.07. And the median was 5.33.

SNWV's Cyclically Adjusted PS Ratio is ranked better than
70.32% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs SNWV: 1.06

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SANUWAVE Health's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.006. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


SANUWAVE Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for SANUWAVE Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Cyclically Adjusted PS Ratio Chart

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.20 8.75 8.59 1.20 0.70

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.20 2.24 1.20 1.11 0.70

Competitive Comparison of SANUWAVE Health's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, SANUWAVE Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Cyclically Adjusted PS Ratio falls into.



SANUWAVE Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SANUWAVE Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.018/0.02
=0.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SANUWAVE Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, SANUWAVE Health's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.006/129.4194*129.4194
=0.006

Current CPI (Dec. 2023) = 129.4194.

SANUWAVE Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.004 99.695 0.005
201406 0.005 100.560 0.006
201409 0.004 100.428 0.005
201412 0.004 99.070 0.005
201503 0.003 99.621 0.004
201506 0.004 100.684 0.005
201509 0.002 100.392 0.003
201512 0.006 99.792 0.008
201603 0.004 100.470 0.005
201606 0.002 101.688 0.003
201609 0.002 101.861 0.003
201612 0.005 101.863 0.006
201703 0.001 102.862 0.001
201706 0.001 103.349 0.001
201709 0.001 104.136 0.001
201712 0.002 104.011 0.002
201803 0.002 105.290 0.002
201806 0.003 106.317 0.004
201809 0.004 106.507 0.005
201812 0.003 105.998 0.004
201903 0.001 107.251 0.001
201906 0.002 108.070 0.002
201909 0.001 108.329 0.001
201912 0.001 108.420 0.001
202003 0.001 108.902 0.001
202006 0.000 108.767 0.000
202009 0.004 109.815 0.005
202012 0.005 109.897 0.006
202103 0.004 111.754 0.005
202106 0.006 114.631 0.007
202109 0.007 115.734 0.008
202112 0.008 117.630 0.009
202203 0.006 121.301 0.006
202206 0.004 125.017 0.004
202209 0.007 125.227 0.007
202212 0.010 125.222 0.010
202303 0.007 127.348 0.007
202306 0.008 128.729 0.008
202309 0.006 129.860 0.006
202312 0.006 129.419 0.006

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SANUWAVE Health  (OTCPK:SNWV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SANUWAVE Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105